They do this with the knowledge that, if somehow they do find an intervention to extend the human lifespan, it will almost certainly be too expensive for the average person to afford, which would create two entirely different classes of humans — one group with money that can see 150, and another that just has to take whatever small insights trickle down from the top.
“The disparity of wealth in the United States will create a “class of immortal overlords,” former Facebook President Sean Parker said at a cancer innovation event last November. “Because I’m a billionaire, I’m going to have access to better healthcare so… I’m going to be, like, 160 and I’m going to be part of this class of immortal overlords.”